PAYER POLICY CHANGES

C9053 Insurance Policy Changes

HCPCS C9053 is officially defined as "Injection, crizanlizumab-tmca, 1 mg." HCPCS C9053 is referenced in 3 tracked payer policy changes from Michigan Medicaid - MDHHS, Indiana Medicaid (IHCP), and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS C9053 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch C9053

Get one email when a payer policy names C9053, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for C9053

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for C9053 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.